Probiotics for prevention of recurrent urinary tract infections in women: A review of the evidence from microbiological and clinical studies

Drugs

Volumn 66, Issue 9, 2006, Pages 1253-1261

  Falagas, Matthew E ^a,b   Betsi, Gregoria I ^a   Tokas, Theodoros ^a   Athanasiou, Stavros ^c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; CTV 05; NORFLOXACIN; PROBIOTIC AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL THERAPY; BACTEREMIA; CANCER; CELL CULTURE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG USE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LACTOBACILLUS; LONG TERM CARE; NONHUMAN; PATHOPHYSIOLOGY; PH; PREVALENCE; PROPHYLAXIS; QUESTIONNAIRE; RECURRENT DISEASE; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION;

ANIMALS; FEMALE; HUMANS; PROBIOTICS; RECURRENCE; URINARY TRACT INFECTIONS;

ANIMALIA; LACTOBACILLUS RHAMNOSUS;

EID: 33745929346     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666090-00007     Document Type: Review

References (46)

1. Foxman B, Barlow R, D'Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509-15
2. Reid G, Jass J, Sebulsky T, et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16: 658-72
3. Senok A, Ismaeel A, Botta G. Probiotics: facts and myths. Clin Microbiol Infect Dis 2005; 11 (12): 958-66
4. De Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr 2002; 88: S59-66
5. Antonio M, Hawes S, Hillier S. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonised by these species. J Infect Dis 1999; 180: 1950-6
6. Zhou X, Bent SJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004; 150: 2565-73
7. Burton J, Cardieux P, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003; 69: 97-101
8. Bruce AW, Chadwick P, Hassan A, et al. Recurrent urethritis in women. CMAJ 1973 Apr; 108 (8): 973-6
9. Stamm W, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723-5
10. Keane F, Ison C, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997; 8: 489-94
11. Reid G, Sobel J. Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis 1987; 9: 470-87
12. Hawthorn LA, Reid G. Exclusion of uropathogen adhesion to polymer surfaces by Lactobacillus acidophilus. J Biomed Mater Res 1990; 24 (1): 39-46
13. Velraeds MM, van de Belt-Gritter B, van der Mei HC, et al. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 1998; 47 (12): 1081-5
14. Heineman C, van Hylckama Vlieg JE. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibit adhesion of Enterococcus faecalis 1131. FEMS Microbiol Lett 2000; 190 (1): 177-80
15. Osset J, Bartolome RM, Garcia E, et al. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001; 183 (3): 485-91
16. Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 1987; 138 (2): 330-5
17. McGroaty JA, Reid G. Detection of lactobacillus substance that inhibits Escherichia Coli. Can J Microbiol 1998; 34 (8): 974-8
18. Reid G, Chan RC, Bruce AW, et al. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect Immun 1985; 49 (2): 320-4
19. Herthelius M, Gorbach SL. Elimination of vaginal colonisation with Escherichia coli by administration of indigenous flora. Infect Immun 1989; 57 (8): 2447-51
20. Silva de Ruiz C, Lopez de Bocanera ME, Nader de Macias ME, et al. Effect of lactobacilli and antibiotics on E. coli urinary infections in mice. Biol Pharm Bull 1996; 19 (1): 88-93
21. Asahara T, Nomoto K, Watanuki M, et al. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 2001 Jun; 45 (6): 1751-60
22. Patton DL, Cosgrove Sweeney YT, Antonio MA, et al. Lactobacillus crispatus capsules: single-use safety study in the Macaca nemestrina model. Sex Transm Dis 2003 Jul; 30 (7): 568-70
23. Colodner R, Edelstein H, Chazan B, et al. Vaginal colonisation by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 2003; 5 (11): 767-9
24. Cardieux P, Burton J, Gardiner G, et al. Lactobacillus strains and vaginal ecology. JAMA 2002; 287: 1940-1
25. Reid G, Beuerman D, Heinemann C, et al. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001; 32: 37-41
26. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35: 131-4
27. Morelli L, Zonenenschain D, Del Piano M, et al. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 2004; 38: S107-10
28. Hoesl CE, Altwein JE. The probiotic approach: an alternative treatment option in urology. Eur Urol 2005; 47: 288-96
29. Newman D. Treatment of cystitis by intravesical injections of lactic bacillus cultures. Lancet 1915; II: 330
30. Hagberg L, Bruce AW, Reid G, et al. Colonisation of the urinary tract with live bacteria from the normal fecal and urethral flora in patients with recurrent symptomatic urinary tract infections. In: Kass EH, Svanborg Eden C, editors. Host-parasite interactions in urinary tract infections. Chicago (IL): University of Chicago Press, 1989: 194-7
31. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 1988; 34: 339-43
32. Reid G, Bruce AW, Taylor M. Influence of 3-day antimicrobial therapy and Lactobacillus suppositories on recurrence of urinary tract infection. Clin Ther 1992; 14: 11-6
33. Reid G, Millsap K, Bruce A. Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet 1994; 344: 1229
34. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23: 32-45
35. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent urinary tract infection in women. Scand J Prim Health Care 1994; 12: 239-43
36. Tomoda T, Nakano Y, Kageyama T. Intestinal Candida overgrowth and Candida infection in patients with leukemia: effect of Bifidobacterium administration. Bifidobacteria Microflora 1988; 7: 71-4
37. Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322: 1-5
38. Kontiokari T, Laitinen J, Jarvi L, et al. Dietary factors protecting women from urinary tract infection. J Clin Nutr 2003; 77: 600-4
39. Reid G, Bruce A, Fraser N, et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30: 49-52
40. Husni R, Gordon S, Washington J, et al. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997; 25: 1048-55
41. Borriello S, Hammes W, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80
42. Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur 1994; 92: 45-67
43. Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28: 1159-60
44. Mackay A, Taylor M, Kibbler C, et al. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999; 5: 290-2
45. Adams M, Marteau P. On the safety of lactic acid bacteria from food. Int J Food Microbiol 1995; 27: 263-4
46. Andreu A. Lactobacillus as a probiotic for preventing urogenital infections. Rev Med Microbiol 2004 Jan; 15 (1): 1-6